Sign in
4

Changes in Ownership

Vir Biotechnology, Inc. Filed Acc 0001628280-25-037344

Director sold 22,000 shares at $4.99 ($109,699)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
SATO VICKI L Director 2025-08-01 Sale 10b5-1 −22,000 $4.99 $109,699 1,276,391 D
Open-market sales · 22,000 sh · avg $4.99 · $109,699
Loading xslF345X05/wk-form4_1754324866.xml…